Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
GSK is a leading global biopharma company focused on uniting science, technology, and talent to get ahead of disease together. The company prioritizes innovation in vaccines and specialty medicines, maximizing the increasing opportunities to prevent and treat disease. GSK's R&D strategy focuses on the science of the immune system, human genetics, and advanced technologies, with a strong pipeline across four core therapeutic areas: infectious diseases, HIV, oncology, and immunology/respiratory. The company operates a vast global manufacturing network and is a major provider of vaccines and medicines for respiratory health and HIV through its majority-owned subsidiary, ViiV Healthcare.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on SB Pharmco.